Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases

Crit Rev Oncol Hematol. 2017 Jul:115:67-80. doi: 10.1016/j.critrevonc.2017.04.008. Epub 2017 Apr 23.

Abstract

A systematic literature review was conducted to quantify populations of patients with primary breast cancer in whom bone metastases were detected at study start or during follow-up. Searches were performed in PubMed and EMBASE using terms related to breast cancer and bone metastases. Articles had to have been published 01/01/99-31/12/13, and to report data on the proportion of patients with bone metastases among patients with breast cancer. In total, 156 articles were included in the meta-analysis. A median of 12% of patients with stage I-III breast cancer developed bone metastases during a median follow-up of 60 months. Of patients who developed metastatic disease during follow-up, 55% (median) had bone metastases. Of those with metastatic breast cancer at study start, 58% (median) had bone metastases. These data help to inform on the global burden of bone metastases by defining patient populations that are at risk of developing bone metastases.

Keywords: Bone metastases; Bone metastasis; Breast cancer; Incidence; Prevalence.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Bone Neoplasms / epidemiology
  • Bone Neoplasms / secondary*
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / pathology*
  • Female
  • Humans
  • Neoplasm Staging